insights_auto
Why is ARX up 2.54%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.50
arrow_upward
+2.54%(+0.012) 1D
Nov 18, 3:30:05 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.51
Low
A$0.49
Mkt. cap
174.68M
Avg. vol.
260.07K
Volume
237.73K
P/E ratio
48.10
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.51
Low
A$0.49
Mkt. cap
174.68M
Avg. vol.
260.07K
Volume
237.73K
P/E ratio
48.10
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Benzinga
·
21 minutes ago
Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus
MarketWatch
·
1 hour ago
Stock Market Today: Dow, S&P 500 and Nasdaq set to climb as Nvidia shares rise after boosting guidance; Anthropic expected to price IPO: live updates
Investing.com
·
2 hours ago
The S&P 500 Is at a Crossroads as Nvidia Fails to Impress
www.tokenpost.com
·
56 minutes ago
Nasdaq Gains 0.91% as S&P 500 Futures and Dow Also Advance
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd